Rosmarinic Acid
CAS 20283-92-5
Rosmarinic Acid (CAS 20283-92-5) is a pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 24135.110192307693 nM | 50 | - |
| - | Potency | 15175.47037037037 nM | 27 | - |
| - | MIC | 945.3863636363636 ug.mL-1 | 22 | - |
| - | EC50 | 41650 nM | 8 | - |
| - | IC50 | 0.27515666666666666 ug.mL-1 | 3 | - |
| - | Ki | 5908.966666666667 nM | 3 | - |
| - | Kd | 39600 nM | 2 | - |
| - | EC50 | 3.1 ug.mL-1 | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| ROSMARINIC ACID | 2531311 | SU | MTHSPL |
| rosmarinic acid | 2531311 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Rosmarinic Acid used for in pharmaceutical contexts?
Rosmarinic Acid (CAS 20283-92-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Rosmarinic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Rosmarinic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Rosmarinic Acid also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Rosmarinic Acid.
What clinical phase is Rosmarinic Acid in?
No phase 1-4 clinical development badge is rendered for Rosmarinic Acid because the matched compound identifier rows do not contain a max-phase value.